logo

Agex Therapeutics Inc. (AGE)



Trade AGE now with
  Date
  Headline
11/16/2020 4:08:39 PM AgeX Therapeutics Q3 Loss/share $0.07 Vs. Loss $0.09 Year Ago
10/28/2020 8:04:24 AM AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 To ImStem Biotechnology
9/9/2020 8:06:18 AM AgeX Therapeutics, Lineage Announce Broadening Of Collaborative Relationship With Regard To ESI Stem Cell Lines
8/14/2020 4:15:38 PM AgeX Therapeutics Q2 Loss/share $0.07 Vs. Loss $0.08 Year Ago
6/16/2020 8:08:53 AM AgeX Therapeutics And Pluristyx Enter Manufacturing, Marketing, and Distribution Agreement
6/2/2020 8:06:42 AM AgeX Therapeutics And ImStem Biotechnology Sign Non-Binding LoI For IMS001 For COVID-19 And Other Causes Of ARDS
5/29/2020 8:04:42 AM AgeX Therapeutics And Sernova Announce Research Collaboration
5/21/2020 8:33:44 AM AgeX Therapeutics Appoints Andrea Park As CFO
5/14/2020 4:07:29 PM AgeX Therapeutics Q1 Loss/share $0.08 Vs. Loss $0.09 Year Ago
5/1/2020 8:57:45 AM AgeX Therapeutics Reports Reduction In Projected Cash Expenditures
3/20/2020 9:14:02 AM AgeX Therapeutics Licensee ImStem Announces FDA Has Lifted Hold And Cleared Investigational NDA For IMS001
2/3/2020 8:07:30 AM AgeX Therapeutics Announces Research Collaboration With The University Of California, Irvine
12/26/2019 8:02:24 AM AgeX Therapeutics Announces Drawdown Of $1.3 Mln Of Second Tranche Of Loan Facility From Juvenescence